206 related articles for article (PubMed ID: 9239409)
1. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
Ziporen L; Shoenfeld Y; Levy Y; Korczyn AD
J Clin Invest; 1997 Aug; 100(3):613-9. PubMed ID: 9239409
[TBL] [Abstract][Full Text] [Related]
2. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
4. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
5. Anti-phospholipid syndrome: from patient's bedside to experimental animal models and back to the patient's bedside.
Ziporen L; Shoenfeld Y
Hematol Cell Ther; 1998 Oct; 40(5):175-82. PubMed ID: 9844811
[TBL] [Abstract][Full Text] [Related]
6. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome.
Tanne D; Katzav A; Beilin O; Grigoriadis NC; Blank M; Pick CG; Landenberg Pv; Shoenfeld Y; Chapman J
Neurobiol Dis; 2008 Apr; 30(1):56-64. PubMed ID: 18308578
[TBL] [Abstract][Full Text] [Related]
7. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
[TBL] [Abstract][Full Text] [Related]
8. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
9. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome.
Katzav A; Menachem A; Maggio N; Pollak L; Pick CG; Chapman J
J Autoimmun; 2014 Dec; 55():86-93. PubMed ID: 25150791
[TBL] [Abstract][Full Text] [Related]
10. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice.
Pierangeli SS; Barker JH; Stikovac D; Ackerman D; Anderson G; Barquinero J; Acland R; Harris EN
Thromb Haemost; 1994 May; 71(5):670-4. PubMed ID: 8091396
[TBL] [Abstract][Full Text] [Related]
11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
12. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
Katzav A; Kloog Y; Korczyn AD; Molina V; Blank M; Shoenfeld Y; Chapman J
Immunobiology; 2003; 207(1):47-50. PubMed ID: 12638903
[TBL] [Abstract][Full Text] [Related]
14. Linseed oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome.
Reifen R; Amital H; Blank M; Sklan D; Berkovich Z; Gershwin E; Shoenfeld Y
J Autoimmun; 2000 Nov; 15(3):381-5. PubMed ID: 11040078
[TBL] [Abstract][Full Text] [Related]
15. Multiple injections of anti-mouse β2glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction (FGR) in mice.
Kawaguchi R; Nunomura S; Umehara N; Nikaido T; Huppertz B; Tanaka T; Ra C
Placenta; 2012 Jul; 33(7):540-7. PubMed ID: 22538230
[TBL] [Abstract][Full Text] [Related]
16. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of antiphospholipid antibody-associated pregnancy complications.
Abrahams VM
Thromb Res; 2009 Nov; 124(5):521-5. PubMed ID: 19665761
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies.
Shrot S; Katzav A; Korczyn AD; Litvinju Y; Hershenson R; Pick CG; Blank M; Zaech J; Shoenfeld Y; Sirota P; Chapman J
Lupus; 2002; 11(11):736-43. PubMed ID: 12475004
[TBL] [Abstract][Full Text] [Related]
19. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
